| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.2M | +766.2% |
| Cost of Revenue | $85K | — |
| R&D Expense | $58.9M | +11.5% |
| SG&A Expense | $114.0M | +137.1% |
| Operating Income | -$171.8M | -70.5% |
| Income Tax | $0 | — |
| Net Income | -$177.1M | -73.7% |
| EPS (Basic) | -$0.80 | -29.0% |
| EPS (Diluted) | -$0.80 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.5M | -51.5% |
| Short-term Investments | $147.6M | +60.4% |
| Accounts Receivable | $1.0M | +3507.1% |
| Inventory | $381K | — |
| Current Assets | $176.5M | +25.3% |
| Total Assets | $229.4M | +18.1% |
| Current Liabilities | $31.5M | +36.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$161.9M | -82.2% |
| Capital Expenditures | $470K | -64.6% |
| Investing Cash Flow | -$49.9M | +29.7% |
| Financing Cash Flow | $188.0M | +32.2% |
| Free Cash Flow | -$162.4M | -80.1% |
| -29.0% |
| Long-term Debt |
| $99.5M |
| +104.7% |
| Total Liabilities | $136.3M | +76.6% |
| Stockholders' Equity | $93.1M | -20.5% |